Hmf Intensive 500 (30 Sachets)

No reviews

The highest concentration of CFU available in Canada • 500 billion CFU per dose • Contains probiotics to replenish normal gut microbiota after antibiotic therapy • Helps improve irritable bowel syndrome (IBS) symptoms in six weeks^† • Offers five exclusive strains from a combination of Lactobacillus and Bifidobacterium genera • Convenient once-daily powder format • Potency guaranteed to expiration • Backed by over 20 years of clinical evidence HMF Intensive 500 is our most concentrated probiotic formula to date, providing 500 billion CFU daily from a combination of five human-sourced, research-driven strains. This blend includes three Lactobacillus and two Bifidobacterium strains to support colonization of both the small and large intestines.¹ These exclusive strains were selected based on their high quality, viability, strong epithelial adherence and naturally high tolerance to stomach acid.² The efficacy of HMF probiotics has been evaluated in clinical trials over the past 15 years and are among the most-researched probiotic cultures in the world.^3-8 Research has reported that the strains present in HMF Intensive 500 contribute to a favourable gut flora, replenish normal gut microbiota after antibiotic therapy, and help improve irritable bowel syndrome (IBS) symptoms in adults and children over 11 years of age, such as bloating, bowel habit satisfaction and pain days, within six weeks.^3-5 Supplied in a convenient once-daily powder format, HMF Intensive 500 is an easy way to support daily gastrointestinal health.^†Adults and children 11 years and older REFERENCES 1. Govender, M, Choonara, YE, Kumar, P, du Toit, LC, van Vuuren, S, Pillay, V. AAPS PharmSciTech. 2014, 15(1): 29-43. 2. Seroyal. Internal data. 3. Madden, JA, Plummer, SF, Tang, J, Garaiova, I, Plummer, NT, Herbison, M, Hunter, JO, Shimada, T, Cheng, L, Shirakawa, T. Int Immunopharmacol. 2005, 5(6): 1091-1097. 4. Plummer, SF, Garaiova, I, Sarvotham, T, Cottrell, SL, Le Scouiller, S, Weaver, MA, Tang, J, Dee, P, Hunter, J. Int J Antimicrob Agents. 2005, 26(1): 69-74. 5. Williams, EA, Stimpson, J, Wang, D, Plummer, S, Garaiova, I, Barker, ME, Corfe, BM. 2009, 29(1): 97-103.